For research use only
| Cat No. | ABC-TC0475 |
| Product Type | Human Liver Cancer Cell Lines |
| Cell Type | Epithelial-like |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Hepatocellular Cancer |
| Product Code | Jhh-7; JHH7; FLC-7; FLC7; Functional Liver Cell-7 |
Utilize JHH-7 to study HBV-associated hepatocellular carcinoma, liver cirrhosis progression, and hepatic biomarker expression in cancer models.
JHH-7 is a human hepatocellular carcinoma (HCC) cell line that was originally isolated from the liver tissue of a 53-year-old male patient with Hepatocellular Carcinoma accompanied by cirrhosis. The adherent cells exhibit polygonal morphology typical of hepatocytes with prominent nucleoli and abundant cytoplasm. JHH-7 cells express hepatocyte markers such as albumin and alpha-fetoprotein (AFP), along with oncogenic proteins like beta-catenin and glypican-3. Cytogenetic profiling reveals chromosomal abnormalities common in HCC, including gains in chromosome 8q. The cell line demonstrates strong tumorigenicity and moderate metastatic potential in immunodeficient mouse models, making it suitable for studying liver cancer progression and therapeutic interventions.
| Product Code | Jhh-7; JHH7; FLC-7; FLC7; Functional Liver Cell-7 |
| Species | Human |
| Cat.No | ABC-TC0475 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial-like |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Liver |
| Disease | Hepatocellular Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Liver Cancer Cell Lines |
JHH-7 cells are widely used in hepatocellular carcinoma research to investigate tumor biology, drug resistance mechanisms, and hepatocyte-specific gene expression. The cell line supports preclinical testing of anti-HCC drugs, including targeted therapies and immunotherapies. Its ability to form tumors in vivo allows studies on tumor growth, angiogenesis, and metastasis, facilitating translational cancer research.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
